Xinyuan Bai

1PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Dec 01, 2025
Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring.

Jiayao Ni, Yi Sun, Hao Cheng

Pageof 1

Frequent Collaborators

1 joint publications

Jiayao Ni

1 joint publications

Yi Sun

1 joint publications

Hao Cheng

1 joint publications

Fan Tong